ArticleCancer medicine2024

Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis.

Takanori Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.